References
- Hasse LA, Ritchey PN, Smith J. Predicting the number of headache visits by type of patient seen in family practice. Headache 2002;42:738-46
- International Classification of Disorders: Committee of the International Headache Society. Classification and diagnosis criteria for headache disorders, cranial neuralgia and facial pain. Cephalalgia 2004;24(Suppl 1):1-150
- Leonardi M, Mathers C. Global burden of migraine in the year 2000: summary of methods and data sources. Global Burden of Diseases 2000. [accessed who.org accessed April 2008]
- Brandes JL. The migraine cycle: patient burden of migraine during and between migraine attacks. Headache 2008;48:430-41
- Lipton RB, Diamond S, Reed M, et al. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 2001;41:638-45
- MacGregor EA, Brandes J, Eikermann A. Migraine prevalence and treatment patterns: the global migraine and zolmitriptan evaluation survey. Headache 2003;43:19-26
- Lucas C, Chaffaut C, Artaz M-A, et al. FRAMIG 2000: medical and therapeutic management of migraine in France. Cephalalgia 2004;25:267-79
- Vuillaume de Diego E, Lanteri-Minet M. Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT). Cephalalgia 2004;25:184-90
- Linde M, Dahlof C. Attitudes and burden of disease among self-considered migraineurs- a nation-wide population-based survey in Sweden. Cephalalgia 2004;24:455-65
- Lipton RB, Scher AI, Steiner TJ , et al. Patterns of health care utilization for migraine in England and in the United States. Neurology 2003;60:441-8
- Understanding the needs of migraine patients. Drugs 2006;66(Suppl 3):1-8
- Wenzel RG, Sarvis CA, Krause ML. Over-the-counter drugs for acute migraine attacks: literature review and recommendations. Pharmacotherapy 2003;23:494
- Diamond S, Bigal ME, Silberstein S, et al. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American migraine prevalence and prevention study. Headache 2007;47:355-63
- Ferrari MD, Goadsby PJ, Roon KI, et al. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 2002;22:633-58
- Strategies to improve migraine treatment results. Drugs 2006;66(Suppl 3):9-16
- Goadsby PJ, Zanchin G, Geraud G, et al. Early vs. non-early intervention in acute migraine – “Act when Mild (AwM). A double-blind, placebo-controlled trial of almotriptan. Cephalalgia 2008;28:383-91
- Pavone E, Banfi R, Vaiani M, Panconesi A. Patterns of triptans use: a study based on the records of a community pharmaceutical department. Cephalalgia 2007;27:1000-4
- Géraud G, Lantéri-Minet M, Lucas C, et al. French guidelines for the diagnosis and management of migraine in adults and children. Clin Ther 2004;26:1305-18
- Ferrari A, Pasciullo G, Savino G, et al. Headache treatment before and after the consultation of a specialized centre: a pharmacoepidemiology study. Cephalalgia 2004;24:356-62